Our data indicates that active ATM signaling is indeed necessary for mitochondrial structural integrity in cancer cells similar to normal physiological conditions and SIRT3 stimulation does not alleviate structural changes in mitochondria in ATM deficient DLBCL cells. The gene discussed is ATM; the disease is cancer.